Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer. - Azorsa DO; Gonzales IM; Basu GD; Choudhary A; Arora S; Bisanz KM; Kiefer JA; Henderson MC; Trent JM; Von Hoff DD; Mousses S (Journal of translational medicine, 2009)